Breakthrough for MRSA vaccination

A vaccine that contains four staphylococcus bacteria proteins can effectively protect against MRSA infection, a US study in mice has found.

The researchers showed that the vaccine, developed using a novel technique known as reverse vaccinology, was effective at preventing a number of strains of the infection.

Previous attempts to develop an MRSA vaccine using killed or live attenuated bacteria have only provided partial immunity.

The researchers tried to create a vaccine that would provide much broader protection against MRSA by recognising the specific cell-surface proteins responsible for the virulence of the bacteria.

Eight staphylococcal genome sequences were analysed, leading to the identification of 19 surface proteins that are present in all known strains of MRSA.

The researchers then vaccinated mice with each protein to see which would give immunity to Staphylococcus aureus infection.

Four proteins provided significant reduction in bacterial load. These were then used to create a single vaccine, which was given to mice that were subsequently infected with one of five MRSA strains.

Mice given the vaccine had a significantly improved survival rate for all strains. Against two of the strains, the vaccine produced 100 per cent survival, compared with 20 and 40 per cent survival in unvaccinated mice.

Dr Olaf Schneewind, professor of microbiology at the University of Chicago and director of the study, described this as an important breakthrough.

‘This organism has learned how to evade nearly all of our current antibiotics. So, generating protective immunity against invasive MRSA has become an important goal,’ he said.

PNAS 2006; 103: 16,942–7

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...

Medeconomics Live aims to help practices thrive under the new GP contract

Medeconomics Live aims to help practices thrive under the new GP contract

The one-day, virtual Medeconomics Live conference aims to provide practices with...

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GP practices have faced a wave of abuse and complaints after a letter from NHS England...

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

The government has denied plans to make GPs 'gatekeepers' of the struggling COVID-19...